AXOVIA THERAPEUTICS Trademark

Trademark Overview

On Thursday, July 2, 2020, a trademark application was filed for AXOVIA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AXOVIA THERAPEUTICS trademark a serial number of 90032649. The federal status of this trademark filing is REGISTERED as of Tuesday, September 6, 2022. This trademark is owned by Jaguar Gene Therapy, LLC. The AXOVIA THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development in the field of gene therapy for the treatment of ciliopathies
axovia therapeutics

General Information

Serial Number90032649
Word MarkAXOVIA THERAPEUTICS
Filing DateThursday, July 2, 2020
Status700 - REGISTERED
Status DateTuesday, September 6, 2022
Registration Number6840057
Registration DateTuesday, September 6, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 1, 2020

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesScientific research and development in the field of gene therapy for the treatment of ciliopathies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 29, 2020
Primary Code042
First Use Anywhere DateThursday, February 25, 2021
First Use In Commerce DateThursday, February 25, 2021

Trademark Owner History

Party NameJaguar Gene Therapy, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressLake Forest, IL 60045
Party NameJaguar Gene Therapy, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLake Forest, IL 60045
Party NameJaguar Gene Therapy, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLake Forest, IL 60045

Trademark Events

Event DateEvent Description
Tuesday, September 6, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 6, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 2, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 1, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 25, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, July 22, 2022USE AMENDMENT FILED
Monday, July 25, 2022SOU EXTENSION 3 GRANTED
Friday, July 22, 2022SOU EXTENSION 3 FILED
Friday, July 22, 2022TEAS EXTENSION RECEIVED
Friday, July 22, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, February 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 2, 2022SOU EXTENSION 2 GRANTED
Tuesday, January 25, 2022SOU EXTENSION 2 FILED
Wednesday, February 2, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 25, 2022TEAS EXTENSION RECEIVED
Saturday, July 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 22, 2021SOU EXTENSION 1 GRANTED
Thursday, July 22, 2021SOU EXTENSION 1 FILED
Thursday, July 22, 2021TEAS EXTENSION RECEIVED
Tuesday, January 26, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 1, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 1, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 26, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 13, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, October 13, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 13, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, October 13, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, October 8, 2020ASSIGNED TO EXAMINER
Wednesday, July 29, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 6, 2020NEW APPLICATION ENTERED

Related Keywords

therapeutics axovia therapy treatment ciliopathies gene field research development scientific